Bortezomib Impurity 45 | CAS 1255646-95-7 - Request Quote
Bortezomib Impurity 45
| SZ CAT No: | SZ-B004082 |
| CAS No | 1255646-95-7 |
| Mol.F. | C17H18N2O3 |
| Mol.Wt. | 298.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Bortezomib Impurity 45 is chemically (S)-2-((S)-2-amino-3-phenylpropanamido)-2-phenylacetic acid. Bortezomib Impurity 45 is supplied with detailed characterization data compliant with regulatory guideline. Bortezomib Impurity 45 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bortezomib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1255646-95-7
Purchase 1255646-95-7
Order 1255646-95-7
Enquire 1255646-95-7
price of 1255646-95-7
1255646-95-7 Supplier
1255646-95-7 Manufacturer
1255646-95-7 Exporter
buy high quality Bortezomib Impurity 45
Purchase Bortezomib Impurity 45
Bortezomib Impurity 45 suppliers
Bortezomib Impurity 45 manufacturers
Bortezomib Impurity 45 price
Order Bortezomib Impurity 45
Enquire Bortezomib Impurity 45
Bortezomib Impurity 45 cost
Bortezomib Impurity 45 Supplier
Bortezomib Impurity 45 Distributor
Bortezomib Impurity 45 for Method Validation
Bortezomib Reference Standard
Bortezomib Impurity 45 for ANDA Filing
Bortezomib Impurity 45 for Forced Degradation Studies
Bortezomib Impurity 45 Identification Standards
Bortezomib Impurity 45 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.